Science Explorer Back to mapMap
Institution · VaxTrials (Panama)

Most cited papers from VaxTrials (Panama)

What are the most cited papers from VaxTrials (Panama)?

The most cited paper from VaxTrials (Panama) is "Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial" (Edwin Jose Asturias, Ananda Sankar Bandyopadhyay, Steve G Self et al., 2016), with 83 citations. Next come "Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials" (81) and "Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study" (77).

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial Edwin Jose Asturias, Ananda Sankar Bandyopadhyay, Steve G Self et al. · The Lancet Open access 21 May 2016 83
2 Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials Xavier Sáez‐Llorens, Ananda Sankar Bandyopadhyay, Christopher Gast et al. · The Lancet Open access 9 Dec 2020 81
3 Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study Miguel O’Ryan, Ananda Sankar Bandyopadhyay, Rodolfo Villena et al. · The Lancet Infectious Diseases Open access 26 Aug 2015 77
4 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil Sue Ann Costa Clemens et al. · Nature Communications Open access128 authors 6 Oct 2021 54
5 Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial Xavier Sáez‐Llorens, Ralf L. Clemens, Geert G Leroux-Roels et al. · The Lancet Infectious Diseases Open access 21 Dec 2015 44
6 Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials Christopher Gast, Ananda Sankar Bandyopadhyay, Xavier Sáez‐Llorens et al. · The Journal of Infectious Diseases Open access 4 Oct 2021 19
7 Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic Luis Rivera Mejía, Lourdes Peña Méndez, Ananda Sankar Bandyopadhyay et al. · The Lancet Infectious Diseases Open access 15 Dec 2023 12
8 Insight and benefits from vaccine clinical trials with adaptive designs: a scoping review Andrés Mauricio García Sierra, Luz Adriana Urbina Moreno, Chloe Flanigan et al. · Translational and Clinical Pharmacology Open access 2025 1
9 The Effect of Spermidine Supplementation on Cognitive Function in Adults: A Mini-Review Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia et al. · Principles and Practice of Clinical Research Journal ReviewOpen access 27 Nov 2023 1
10 P-622. Population-Based Longitudinal Maternal and Birth Cohort of Prevalent Respiratory Tract Infections in Children from 0 to 5 years of age Eduardo López-Medina, Rodrigo De Antonio, Xavier Sáez‐Llorens et al. · Open Forum Infectious Diseases Open access 2026 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.